http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
대구 , 경북 지역 혈액투석 환자에서 C 형 간염의 유병율
신영호(Young Ho Shin),김양식(Yang Sik Kim),김호규(Ho Kyu Kim),최성대(Sung Dae Choi),신현수(Hyun Su Shin),원영준(Young Jun Won),이일세(Ill Sae Lee),강문규(Mun Kyu Kang),이정호(Jung Ho Lee),박성배(Sung Bae Park),김현철(Hyun Chul Kim) 대한내과학회 1998 대한내과학회지 Vol.54 No.5
To determine the prevalence and risk factor of anti-HCV in ESBD patients under chronic maitenance hemodialysis, the prevalence of serum antibodies to hepatitis C Virus (Anti-HCV) was assessed by an enzyme immunoassay (Abbott HCV EIA) in 253 patients with long-term Hemodialysis in Daegu & Kyoungbuk. 15 patients (5.9%) were anti-HCV positive. All dialysis patients had the history of transfusion. The number of transfusion units was not significant in anti-HCV positive patients (mean 17±20 pints) in comparison with the number in anti-HCV negative patients (mean 16±17 pints). The frequency of hemodialysis was also not significant in anti-HCV positive patients (mean 477±618 ) compared with anti-HCV negative patients (mean 462±616). The mean duration of hemodialysis was significantly higher (p<0.001) in the anti-HCV positive patients (74±42 months) in comparison with anti-HCV negative patients (45±41 months). We concluded that the prevalence of anti-HCV in hemodialysis patients is 5.9% and that HCV infection is significantly mlated with the duration of hemodialysis rather than the number of transfusion units and the frequency of hemodialysis